Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer (Q36670959)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 January 2012
edit
Language Label Description Also known as
English
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
scientific article published on 17 January 2012

    Statements

    Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit